-- NACLインダストリーズ(NSE:NACLIND、BOM:524709)は、3月31日を期末とする第4四半期決算において、連結純損失を前年同期の5億インドルピーから860万インドルピーに縮小した。 農薬メーカーである同社は、インド証券取引所への提出書類の中で、1株当たり損失も前年同期の2.31インドルピーから0.04インドルピーに縮小したと発表した。 第4四半期の営業収益は、前年同期の20億1000万インドルピーから36億1000万インドルピーに増加した。 同社の株価は火曜日の終値で約4%上昇した。
Related Articles
Research Alert: Ingr: Tough Start To Year As Operational Disruptions Continue; Guidance Cut
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:INGR delivered disappointing Q1 results with adj. EPS of $2.34 (-21% Y/Y), missing consensus by $0.13, while net sales declined 1% to $1,792M, in line with expectations. Adj. operating income dropped 22% to $212M, with the Food & Industrial Ingredients - U.S./CAN segment particularly weak as operating income plunged 63% to $34M due to ongoing Argo facility disruptions. The company cut its 2026 outlook, now expecting adj. EPS of $10.45-$11.15 (from $11.00-$11.80) and net sales flat to up low single digits. Management indicated the Argo facility recovery has taken longer than expected following the 2025 thermal event, with sequential improvement anticipated in Q2 2026 and a return to normal operations targeted for H2 2026. We are disappointed with the results as our expectation was that the Argo facility issues would have been resolved by now, though we expect gradual improvement as operational challenges normalize in the second half.
Research Alert: It: Growth Metrics Fight Off Deceleration But Remain Stuck; Margins Impress
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:IT reported Q1 2026 sales of $1.51B (-1.5% Y/Y, -4.3% ex-FX), near consensus of $1.52B, with Insights (87% of total) flat Y/Y to continue a deceleration from +1% in Q4 and +4% in Q3. Non-GAAP EPS of $3.32 (+11%) beat Street estimates of $2.92, helped by Insights contribution margin expanding 110 bps Q/Q to 78.2% and strong buyback activity of $535M. Global CV growth remains stuck, growing by just 1.0% Y/Y to $5.3B, but these results improved from 0.8% in Q4, reversing a multi-quarter deceleration. We expect CV growth to improve from here on AskGartner momentum. Wallet retention of 77.7% (+20 bps Q/Q, -530 bps Y/Y) and Client retention of 85.0% (-30 bps Q/Q, +60 bps Y/Y) were largely unchanged Q/Q. FY 26 sales guidance was revised from >$6.455B to >$6.405B (-1% Y/Y), with Q1's weak Consulting results (-17%) contributing the entirety of the reduction, which may spook investors worried about AI competition. Still, IT raised its EPS forecast to >$13.25 (flat Y/Y) from >$12.30 prior, providing decent support.
USA Compression Partners Adds Horsepower in Q1 with J-W Power Acquisition, Usage Intensity Slips
USA Compression Partners (USAC) said Tuesday its Q1 average horsepower utilization stood at 91.9%, down from 94.4% for Q1 2025, when total active horsepower was a smaller 3.56 million.The company said its acquisition of J-W Power and parent J-W Energy added 800,000 active horsepower across the Northeast, Midcontinent, Rockies, Gulf Coast and the Permian Basin, taking its total to 4.4 million active horsepower.CEO Clint Green said that the acquisition was particularly timely given the fact that new engine procurement lead times have recently begun to exceed two years.USA Compression Partners is one of the largest independent natural gas compression services in the country in terms of compression fleet horsepower.The company's customer base comprises producers, processors, gatherers and transports of natural gas and crude oil.